Derval joined InflaRx as VP, Head of Regulatory Affairs in 2022. She has over 30 years of experience in Regulatory Affairs with the last 19 years in senior management positions contributing strategically to global product development and commercialisation activities. She has previously held positions as VP, Global Regulatory and Quality at rare disease company Amryt Pharmaceuticals for 5 years, Senior Director of Regulatory Affairs at rare disease company Travere for 2 years and Managing Consultant at Regulatory Consultancy, Real Regulatory for 11 years where she worked on numerous drug development programs for international clients. She gained prior experience in a number of roles which included drug, device and IVD products. Derval has an proven track record of leading global registration activities for innovative new products and is experienced in guiding teams through FDA and EMA regulatory agency interactions for pre-authorisation, authorisation and complex post marketing commitments. Derval has an M.Sc in Biochemistry and an M.B.A from University College, Dublin.